May 13, 2019 / NTS GMT
Presentation
May 13, 2019 / NTS GMT
=====================
Corporate Participants
=====================
* Hiroshi Nomura
Sumitomo Dainippon Pharma Co., Ltd. - CEO, President & Representative Director
* Nobuhiko Tamura
Sumitomo Dainippon Pharma Co., Ltd. - Senior Executive Officer, Executive Director, & Head of Global Clinical Development
=====================
Conference Call Participants
=====================
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
* Hidemaru Yamaguchi
Citigroup Inc, Research Division - MD and Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Motoya Kohtani
Nomura Securities Co. Ltd., Research Division - Senior Analyst
* Seiji Wakao
Mitsubishi UFJ Morgan Stanley Securities Co., Ltd., Research Division - Senior Analyst
* Shinichiro Muraoka
Morgan Stanley, Research Division - Research Analyst
* Yasuhiro Nakazawa
SMBC Nikko Securities Inc., Research
Sumitomo Pharma Co Ltd
(STU:DPM)
€
3.5
0.02 (0.57%)
Market Cap: 1.41 Bil
Enterprise Value: 3.06 Bil
PE Ratio: 0
PB Ratio: 2.04
GF Score: 63/100 Full Year 2019 Sumitomo Dainippon Pharma Co Ltd Earnings Presentation Transcript
May 13, 2019 / NTS GMT
Release Date Price:
€19.73
(+2.12%)
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot